-
Mashup Score: 7
AbstractAims. Hyperlipidaemia and inflammation jointly contribute to atherosclerotic disease. Yet, after the initiation of statin therapy, the relative contribu
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
AbstractAims. Hyperlipidaemia and inflammation jointly contribute to atherosclerotic disease. Yet, after the initiation of statin therapy, the relative contribu
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Inflammation drives residual risk in #CKD : a #CANTOS substudy Among statin-treated CANTOS participants with preserved renal function, hsCRP, IL-6, #LDL-C, and non-HDL-C all predicted incident MACE events https://t.co/r29mg2E5Jh @ESC_Journals @escardio @mmamas1973 @DBelardoMD https://t.co/I7VpIQhsDu
-
-
Mashup Score: 0CANTOS Data Show Importance of Inflammation Risk in CKD Patients with Atherosclerosis - 2 year(s) ago
Paul M. Ridker, MD, discusses the latest findings from the canakinumab trial before highlighting his team’s work with ziltevekimab in ZEUS.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
Despite current guideline recommendations, new analysis from #CANTOS show residual inflammation may be a greater target to treat than cholesterol in patients with atherosclerotic disease and impaired kidney function. #ACC22 @BrighamWomens @harvardmed https://t.co/KgRSR4IWBG
-
RT @BartoszHudzik: #inflammation drives residual #risk in post-#MI pts with #CKD: #CANTOS substudy 👉 https://t.co/HoAsOS7QNY #LDL #CRP #IL6…